Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HumaScan president and CEO (Chief Executive Officer) resigns:

This article was originally published in Clinica

Executive Summary

Donald Brounstein, a co-founder of HumaScan, has resigned as president and CEO of the Cranford, New Jersey-based company. HumaScan said it was ready to enter the second phase of its development since Mr Brounstein founded the company and the launch of its first product, the BreastAlert Differential Temperature Sensor device which is used as an adjunctive screening device for breast tumours. Elizabeth Tallett, a HumaScan board member, has been appointed acting CEO and chairman. Mr Brounstein will remain an active board member. HumaScan recently received an FDA warning letter concerning the BreastAlert device (see Clinica No 808, p 16).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT081480

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel